Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001651175-25-000004
Filing Date
2025-11-06
Accepted
2025-11-06 16:10:47
Documents
1
Period of Report
2025-11-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3706
  Complete submission text file 0001651175-25-000004.txt   5174
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHOATE, HALL & STEWART TWO INTERNATIONAL PLACE BOSTON MA 02110
Business Address
Klein Roger M. (Reporting) CIK: 0001651175 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 251458363